Stereotaxis, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
STXS$1.14+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (in thousands, except share amounts) | September 30, 2025 | December 31, 2024 |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $10,506 | $12,217 |
| Restricted cash - current | - | 219 |
| Accounts receivable, net of allowance of $621 and $582 at 2025 and 2024, respectively | 5,333 | 3,824 |
| Inventories, net | 10,147 | 8,331 |
| Prepaid expenses and other current assets | 677 | 1,848 |
| Total current assets | 26,663 | 26,439 |
| Property and equipment, net | 3,156 | 3,573 |
| Goodwill | 3,764 | 3,764 |
| Intangible assets, net | 6,665 | 7,358 |
| Operating lease right-of-use assets | 5,059 | 5,483 |
| Prepaid and other non-current assets | 280 | 107 |
| Total assets | $45,587 | $46,724 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $4,681 | $5,668 |
| Accrued liabilities | 1,969 | 2,922 |
| Deferred revenue | 7,539 | 6,804 |
| Current contingent consideration | 5,558 | 5,638 |
| Current portion of operating lease liabilities | 623 | 570 |
| Total current liabilities | 20,370 | 21,602 |
| Long-term deferred revenue | 607 | 2,064 |
| Long term contingent consideration | 7,016 | 6,126 |
| Operating lease liabilities | 4,960 | 5,436 |
| Other liabilities | 1,100 | 64 |
| Total liabilities | 34,053 | 35,292 |
| Series A - Convertible preferred stock: | ||
| Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized; 21,121 and 21,458 shares outstanding at 2025 and 2024, respectively | 5,268 | 5,352 |
| Stockholders’ equity: | ||
| Common stock, par value $0.001; 300,000,000 shares authorized, 91,088,439 and 85,326,557 shares issued at 2025 and 2024, respectively | 91 | 85 |
| Additional paid in capital | 584,218 | 567,926 |
| Treasury stock, 4,015 shares at 2025 and 2024 | (206) | (206) |
| Accumulated deficit | (577,837) | (561,725) |
| Total stockholders’ equity | 6,266 | 6,080 |
| Total liabilities and stockholders’ equity | $45,587 | $46,724 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.